Evaluation of Sesbania grandiflora for antiurolithiatic and antioxidant properties

Journal of Natural Medicines

Volumn 62, Issue 3, 2008, Pages 300-307

  Doddola, Sujatha ^a   Pasupulati, Haritha ^a   Koganti, Bharathi ^a   Prasad, Koganti V S R G ^a  

^a INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

Author keywords

Antioxidant property; Antiurolithiatic activity; Calcium oxalate stones; Sesbania grandiflora

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; AMMONIUM OXALATE; CATALASE; GENTAMICIN; GLUTATHIONE REDUCTASE; NITRIC OXIDE; OXALIC ACID DERIVATIVE; PLANT EXTRACT; SESBANIA GRANDIFLORA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CALCIUM OXALATE STONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; KIDNEY MASS; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NEPHROLITHIASIS; NONHUMAN; PLANT LEAF; RAT; SESBANIA; SESBANIA GRANDIFLORA; URINARY EXCRETION;

ACUTE TOXICITY TESTS; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CALCIUM; CALCIUM OXALATE; INDIA; KIDNEY; KIDNEY CALCULI; LETHAL DOSE 50; MALE; MEDICINE, TRADITIONAL; ORGAN SIZE; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; SESBANIA;

EID: 44949112228     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-008-0235-2     Document Type: Article

References (38)

1. Ryall RL (1997) Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J Urol 15:155-164
2. Dey AC (1998) Indian medicinal plants used in Ayurvedic preparation. BS Mahandra Pal Singh, Dehradun, pp 111-132
3. Vedhavathi S, Mrudhula V, Sudhakar A (1997) Tribal medicine of Chittor district. Herbal Folklore Research Center, Chittor, pp 110-112
4. Sheth UK, Dandkar NK, Usha GK (1972) Selected topics in experimental pharmacology. Kothari Book Depot, Bombay, pp 124
5. Sanjaykumar, Sigmon D, Miller T, Carpenter B, Khan S, Malhotra R, Schied C, Menon M (1991) A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146:1384-1389
6. Lorentz K (1982) Improved determination of serum calcium with ortho cresolphthalein complexone. Clin Chim Acta 126:327-333
7. Hodgkinson A, Williams A (1972) An improved colorimetric procedure for urinary oxalate. Clin Chim Acta 36:127-132
8. Naveen T, Sangeeta P, Anurag K, Chopra K (2005) Hesperidine, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetra chloride in rat liver and kidney. BMC Pharmacol 471:221-230
9. Claiborne A (1985) Handbook of methods for oxygen radical research. CRC Press, Boca Raton, FL, pp 283-284
10. Jollow D, Mitchell L, Zampaglione N, Gillete J (1974) Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacol 11:151-169
11. Marcocci L, Maguire JJ, Droy-Lefaix MT (1994) The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biophys Res Commun 201:748-755
12. Blois MS (1958) Antioxidant determination by the use of a stable free radical. Nature 181:1199-1200
13. Menon M, Resnick (2002) Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC et al. (eds) Campbell's urology, 7th edn. WB Saunders, Philadelphia, PA, pp 2661-2733
14. Khan SR (1997) Animal models of kidney stone formation: an analysis. World J Urol 15:236-243
15. Khan SR, Hackett RL (1988) Membrane induced calcium oxalate crystal nucleation. Urol Res 16:185
16. Chahwala SB, Harpur ES (1983) Gentamicin-induced hypercalciuria in the rat. Acta Pharmacol Toxicol 53:358
17. Baumann MJ (1998) Stone prevention: why so little progress? Urol Res 26:77-81
18. Baskar R, Meenalakshmi malini M, Varalakshmi P, Balakrishna K, Bhima Rao R (1996) Effect of Lupeol isolated from Crataeva nurvala stem bark against free radical induced toxicity in experimental urolithiasis. Fitoterapia LXVII 2:121-125
19. Robertson WG, Peacock M (1980) The course of idiopathic calcium disease: hypercalciuria or hyperoxaluaria. Nephron 26:105-110
20. Borghi L, Meschi T, Guerra A, Novanni A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stones recurrences. J Cardiovasc Pharmacol 22:78-86
21. Marshall RW, Robertson WG (1976) Nonograms for the estimation of the saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate. Clin Chim Acta 72:253-257
22. Pak CYC (1981) A cautious use of cellulose phosphate in the management of calcium nephrolithiasis. Invest Urol 19:187-190
23. Grases F, March JG, Ramis M, Costa-Bauza A (1993) The influence of Zea mays on urinary risk factors for kidney stones in rats. Phytother Res 7:146-149
24. Denyer SP (1990) Guide to microbiological control in pharmaceuticals. Ellis Horwood, London, pp 11-28
25. Grases F, Ramis M, Costa-Bauza A, March JG (1995) Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis in rats. J Ethnopharmacol 45:211-214
26. Thamilselvan S, Selvam R (1997) Effect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis. Indian J Biochem Biophys 34:319
27. Scheid C, Koul H, Adam Hill W, Luber Narod L, Kennington L, Honeyman T, Jonassen J, Mani M (1996) Oxalate toxicity in LLC-PK1 cells. Role of free radicals. Kidney Int 49:413-417
28. Scheid C, Honeyman T, Kohjimoto Y, Cao LC, Jonassen J (2000) Oxalate induced changes in renal epithelial cell function: role in stone disease. Mol Urol 4:371-377
29. Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059-1063
30. Bellomo G, Orrenius AL (1985) Alterations in oxidative hepatocellular injury. Hepatology 5:876- 879
31. 2+ dependent ATPase activity in the microsomal fraction of renal tissues in patients with nephrolithiasis and chronic pyelonephritis. Urol Nefrol (Mosk) 5:14-19
32. Selvam R, Bijikurien T (1987) Induction of lipid peroxidation by oxalate in experimental urolithiasis. J Biosci 12:367-371
33. Ialenti A, Moncada S, DiRosa M (1993) Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 10:701-709
34. Ross R (1993) The pathogenesis of atherosclerosis a perspective for the 1990's. Nature 362:801-807
35. Sanchez-Moreno C (2002) Methods to evaluate the free radical scavenging activity in foods and biological systems. Food Sci Tech Int 8:122-128
36. Pari L, Uma A (2003) Protective effect of Sesbania grandiflora against erythromycin estolate-induced hepatotoxicity. Therapie 58:439-443
37. Wong SP, Leong LP, Koh JHW (2006) Antioxidant activities of aqueous extracts of selected plants. Food Chem 99:775-783
38. Ramesh T, Mahesh R, Hazeena Begum V (2007) Effect of Sesbania grandiflora on lung antioxidant defense system in cigarette smoke exposed rats. Int J Biol Chem 1:141-148